Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of temozolomide modulation followed by fotemustine in metastatic melanoma
2009-016487-36Phase 2Active
- Sponsor
- GOIM
- Start
- Mar 2010
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fotemustine and temozolomide in melanoma, sponsored by GOIM. Started Mar 2010; status: active.
02
Drugs
fotemustinetemozolomide
03
Conditions
melanoma
Beyond the preview
Go deeper on 2009-016487-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016487-36.